- Q1 2024 Inovio Pharmaceuticals Inc Earnings Call TranscriptMay 13, 2024$11.36 (+6.67%)Earnings
- Q4 2023 Inovio Pharmaceuticals Inc Earnings Call TranscriptMar 06, 2024$9.87 (+1.96%)Earnings
- Inovio Pharmaceuticals Inc Extraordinary Shareholders Meeting TranscriptJan 12, 2024
- Q3 2023 Inovio Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2023$4.35 (-4.71%)Earnings
- Q2 2023 Inovio Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2023$4.85 (-4.52%)Earnings
- Inovio Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q1 2023 Inovio Pharmaceuticals Inc Earnings Call TranscriptMay 10, 2023$9.72 (-3.33%)Earnings
- Q4 2022 Inovio Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2023$14.88 (-1.59%)Earnings
- Q3 2022 Inovio Pharmaceuticals Inc Earnings Call TranscriptNov 08, 2022$25.68 (-0.47%)Earnings
- Q2 2022 Inovio Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2022$25.2 (-11.02%)Earnings
- Q1 2022 Inovio Pharmaceuticals Inc Earnings Call TranscriptMay 10, 2022$29.88 (+5.06%)Earnings
- Q4 2021 Inovio Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2022$38.88Earnings
- Q3 2021 Inovio Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2021$84.6 (+4.60%)Earnings
- Inovio Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Q2 2021 Inovio Pharmaceuticals Inc Earnings Call TranscriptAug 09, 2021$115.2 (+5.38%)Earnings
- Inovio Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 18, 2021
- Inovio Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 13, 2021
- Inovio Pharmaceuticals Inc Presenting at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Inovio Pharmaceuticals Inc Earnings Call TranscriptMay 10, 2021$80.04 (-2.63%)Earnings
- Q4 2020 Inovio Pharmaceuticals Inc Earnings Call TranscriptMar 01, 2021$139.2 (+4.50%)Earnings
- Q3 2020 Inovio Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2020$102 (-19.28%)Earnings
- Q2 2020 Inovio Pharmaceuticals Inc Earnings Call TranscriptAug 10, 2020$227.88 (-6.08%)Earnings
- Inovio Pharmaceuticals, Inc. - Special Call TranscriptJun 01, 2020
- Inovio Pharmaceuticals Inc Annual Shareholders Meeting TranscriptMay 14, 2020
- Q1 2020 Inovio Pharmaceuticals Inc Earnings Call TranscriptMay 11, 2020$142.8 (+9.63%)Earnings
- Q4 2019 Inovio Pharmaceuticals Inc Earnings Call TranscriptMar 12, 2020$114 (+13.50%)Earnings
- Q3 2019 Inovio Pharmaceuticals Inc Earnings Call TranscriptNov 12, 2019$29.28 (-0.41%)Earnings
- Inovio Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptOct 02, 2019
- Q2 2019 Inovio Pharmaceuticals Inc Earnings Call TranscriptAug 08, 2019$30.48 (+0.40%)Earnings
- Inovio Pharmaceuticals, Inc. - Special Call TranscriptJul 17, 2019
- Q1 2019 Inovio Pharmaceuticals Inc Earnings Call TranscriptMay 09, 2019$46.44 (-0.77%)Earnings
- Q4 2018 Inovio Pharmaceuticals Inc Earnings Call TranscriptMar 12, 2019$42.72 (+1.14%)Earnings
Inovio Pharmaceuticals, Inc. - Special Call Transcript
Good morning. My name is Ben Matone, and I'm Senior Director of Investor Relations at Inovio. We're excited to have you join us for the first ever Inovio webinar entitled DNA Medicines from COVID-19 to Cancer.
Before we begin, I'd like to remind everyone that we will be making certain forward-looking statements regarding future events that relate to our business plans to develop Inovio's integrated platform of DNA Medicines. These include clinical and regulatory developments and timing of clinical data readouts and strategic matters. All of these statements are based on the beliefs and expectations of management as of today. These statements involve certain assumptions, risk and uncertainties and could cause actual results to differ materially. We assume no obligation to revise or update forward-looking statements, whether as a result of new information, future events or otherwise.
Thank you again for being with us today. And with that, I would like to turn the presentation over to Dr. Joseph Kim, President and CEO of Inovio.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)